Redundancy of Progress Notes for Serial Office Visits

Michelle R. Hribar; Adam Rule; Abigail E. Huang; Haley Dusek; Isaac H. Goldstein; Brad Henriksen; Wei Chun Lin; Austin Igelman; Michael F. Chiang

doi:10.1016/j.ophtha.2019.06.015

Redundancy of Progress Notes for Serial Office Visits

Michelle R. Hribar, Adam Rule, Abigail E. Huang, Haley Dusek, Isaac H. Goldstein, Brad Henriksen, Wei Chun Lin, Austin Igelman, Michael F. Chiang

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Original language	English (US)
Pages (from-to)	134-135
Number of pages	2
Journal	Ophthalmology
Volume	127
Issue number	1
DOIs	https://doi.org/10.1016/j.ophtha.2019.06.015
State	Published - Jan 2020

ASJC Scopus subject areas

Ophthalmology

Access to Document

10.1016/j.ophtha.2019.06.015

Cite this

@article{bef4f31e867b4362b7a567ff7f561126,

title = "Redundancy of Progress Notes for Serial Office Visits",

author = "Hribar, {Michelle R.} and Adam Rule and Huang, {Abigail E.} and Haley Dusek and Goldstein, {Isaac H.} and Brad Henriksen and Lin, {Wei Chun} and Austin Igelman and Chiang, {Michael F.}",

note = "Funding Information: Supported by the National Institutes of Health, Bethesda, Maryland (grant nos.: R00LM12238 and P30EY10572); Research to Prevent Blindness, Inc., New York, New York (unrestricted departmental funding); and Children's Hospital of Philadelphia, Philadelphia, Pennsylvania (lecture honorarium [M.R.H.]). The funding organizations had no role in the design or conduct of this research. Financial Disclosure(s): The author(s) have made the following disclosure(s): A.E.H.: Consultant ? Advanced Clinical (Deerfield, IL). M.F.C.: Consultant ? Novartis (Basel, Switzerland); Financial support ? Genentech; Scientific advisory board ? Clarity Medical Systems (Pleasanton, CA); Equity owner ? Inteleretina, LLC (Honolulu, HI); Patent (provisional) ? I-ROP deep learning system. HUMAN SUBJECTS: No human subjects were included in this study. The human ethics committees at Oregon Health and Science University approved the study and granted a waiver of informed consent for analysis of electronic health records data. This study adhered to the tenants of the Declaration of Helsinki. Obtained funding: Hribar, Chiang",

year = "2020",

month = jan,

doi = "10.1016/j.ophtha.2019.06.015",

language = "English (US)",

volume = "127",

pages = "134--135",

journal = "Ophthalmology",

issn = "0161-6420",

publisher = "Elsevier Inc.",

number = "1",

}

TY - JOUR

T1 - Redundancy of Progress Notes for Serial Office Visits

AU - Hribar, Michelle R.

AU - Rule, Adam

AU - Huang, Abigail E.

AU - Dusek, Haley

AU - Goldstein, Isaac H.

AU - Henriksen, Brad

AU - Lin, Wei Chun

AU - Igelman, Austin

AU - Chiang, Michael F.

N1 - Funding Information: Supported by the National Institutes of Health, Bethesda, Maryland (grant nos.: R00LM12238 and P30EY10572); Research to Prevent Blindness, Inc., New York, New York (unrestricted departmental funding); and Children's Hospital of Philadelphia, Philadelphia, Pennsylvania (lecture honorarium [M.R.H.]). The funding organizations had no role in the design or conduct of this research. Financial Disclosure(s): The author(s) have made the following disclosure(s): A.E.H.: Consultant ? Advanced Clinical (Deerfield, IL). M.F.C.: Consultant ? Novartis (Basel, Switzerland); Financial support ? Genentech; Scientific advisory board ? Clarity Medical Systems (Pleasanton, CA); Equity owner ? Inteleretina, LLC (Honolulu, HI); Patent (provisional) ? I-ROP deep learning system. HUMAN SUBJECTS: No human subjects were included in this study. The human ethics committees at Oregon Health and Science University approved the study and granted a waiver of informed consent for analysis of electronic health records data. This study adhered to the tenants of the Declaration of Helsinki. Obtained funding: Hribar, Chiang

PY - 2020/1

Y1 - 2020/1

UR - http://www.scopus.com/inward/record.url?scp=85069685898&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85069685898&partnerID=8YFLogxK

U2 - 10.1016/j.ophtha.2019.06.015

DO - 10.1016/j.ophtha.2019.06.015

M3 - Article

C2 - 31358388

AN - SCOPUS:85069685898

VL - 127

SP - 134

EP - 135

JO - Ophthalmology

JF - Ophthalmology

SN - 0161-6420

IS - 1

ER -